Opexa Therapeutics (OPXA) Files $35 Mixed Shelf
Tweet
Share
E-mailGet Alerts OPXA Hot Sheet
Join SI Premium – FREE
Opexa Therapeutics, Inc. (NASDAQ: OPXA) has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission ("SEC").
Under the shelf registration statement, when declared effective by the SEC, Opexa may offer and sell from time to time in the future, in one or more public offerings, up to $35 million of common stock, debt securities, preferred stock, depository shares, warrants, or any combination thereof.
Under the shelf registration statement, when declared effective by the SEC, Opexa may offer and sell from time to time in the future, in one or more public offerings, up to $35 million of common stock, debt securities, preferred stock, depository shares, warrants, or any combination thereof.
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
S3Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
